NCT04660786Phase 1/2Status unknown
Intralesional Vitamin D in Alopecia Areata
Intralesional Vitamin D3 Injection in Treatment of Alopecia Areata: A Novel Approach
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Status unknown
- Declared phase
- Phase 1/2
- Sponsor
- Alexandria University
- Participants (registry)
- 40
- Start
- November 2021
- Primary completion
- December 2022
- Study completion
- December 2022
- Last registry update
- July 2021
- Countries
- Egypt
Conditions studied: Alopecia Areata
Interventions: triamcinolone acetonide, vitamin D
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.